Join the ReadytoScreen trial to support lung cancer screening

The National Lung Cancer Screening Program will begin on 1st July 2025, and eligible participants will need a referral from their GP to be screened. Early detection through screening significantly improves outcomes for patients at high risk of lung cancer.

The ReadytoScreen trial aims to identify the most effective strategies for engaging eligible patients to take up lung cancer screening.  

General practices participating in the trial will:

  • Be supported to identify patients who may be eligible for screening.

  • Gain access to Future Health Today, a point-of-care clinical decision support tool, integrated into your existing software.

  • Receive a list of patients interested in being contacted for eligibility assessment.

  • Be supported onsite by one of our research nurses.

  • Receive $2000 AUD reimbursement for your time, with your clinical staff eligible to claim up to 4.5 continuing professional development (CPD) hours for participation. 

     

Eligible practices must:

  • Have at least two full-time equivalent GPs and a practice manager (or delegate).

  • Use electronic medical record (EMR) software (e.g., Best Practice, Medical Director, ZedMed) and be able to extract patient cohort lists.

  • Have the ability to send SMS reminders to patients. 

For more information, please email ready-to-screen@unimelb.edu.au or call 0459 867 617. A member of the research team will reach out to discuss your involvement.

Learn more
Margot Schoonmaker